Wakefield, MA · Founded 2011 · Privately Held (backing)
Developer of catheter-based neurolytic delivery systems designed for therapeutic intervention in hypertension. Ablative Solutions is based in Wakefield, MA and was founded in 2011. Its last reported valuation was $140 million in Jun 2022. It has raised $215 million across 4 recorded rounds; the latest was a $10.4 million early-stage round in Nov 2025.
Last reported valuation
$140.0M
Oct 2026
Priced at
—
Total raised
$214.6M
Last round
Early Stage VC
Nov 2025
No prints on record
No secondary trades in Ablative Solutions shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ablative Solutions with a free account
·The complete investor list: 11 names
·Watch Ablative Solutions: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Ablative Solutions stock.
